Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.0290
Abstract: This cohort study assesses the association of upfront peptide receptor radionuclide therapy (PRRT) vs upfront chemotherapy or targeted therapy with progression-free survival among patients in Italy with enteropancreatic neuroendocrine tumors who experienced disease progression after… read more here.
Keywords: receptor radionuclide; association upfront; progression; peptide receptor ... See more keywords
Efficacy and Safety of Oral Small Molecule Glucagon-Like Peptide 1 Receptor Agonist Danuglipron for Glycemic Control Among Patients With Type 2 Diabetes
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.14493
Abstract: Key Points Question Among adults with type 2 diabetes (T2D), what is the efficacy, safety, and tolerability of the novel, orally administered, small molecule glucagon-like peptide 1 receptor agonist danuglipron? Findings In this phase 2… read more here.
Keywords: efficacy safety; like peptide; peptide receptor; glucagon like ... See more keywords
Association of Prescription Co-payment With Adherence to Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapies in Patients With Heart Failure and Diabetes
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.16290
Abstract: This cohort study compares rates of 1-year adherence to glucagon-like peptide-1 receptor agonist or sodium-glucose cotransporter 2 inhibitor therapies by co-payment level among US adults with type 2 diabetes and/or heart failure. read more here.
Keywords: agonist sodium; peptide receptor; glucagon like; adherence glucagon ... See more keywords
Bariatric Metabolic Surgery vs Glucagon-Like Peptide-1 Receptor Agonists and Mortality
Sign Up to like & getrecommendations! Published in 2024 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2024.15392
Abstract: Key Points Question How are bariatric metabolic surgery (BMS) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) associated with mortality and major adverse cardiovascular events (MACEs) among patients with obesity and diabetes? Findings In this cohort study… read more here.
Keywords: like peptide; mortality; peptide receptor; metabolic surgery ... See more keywords
Food Retention at Endoscopy Among Adults Using Glucagon-Like Peptide-1 Receptor Agonists
Sign Up to like & getrecommendations! Published in 2024 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2024.36783
Abstract: This cross-sectional study investigates the association between glucagon-like peptide-1 receptor agonists and food retention during esophagogastroduodenoscopy. read more here.
Keywords: food retention; like peptide; receptor agonists; peptide receptor ... See more keywords
Knocking down the sex peptide receptor by dsRNA feeding results in reduced oviposition rate in olive fruit flies.
Sign Up to like & getrecommendations! Published in 2020 at "Archives of insect biochemistry and physiology"
DOI: 10.1002/arch.21665
Abstract: Insect pests can cause crop damage in yield or quality, resulting in profit losses for farmers. The primary approach to control them is still the use of chemical pesticides resulting in significant hazards to the… read more here.
Keywords: insects; sex peptide; peptide receptor;
Selective Display of a Chemoattractant Agonist on Cancer Cells Activates the Formyl Peptide Receptor 1 on Immune Cells **
Sign Up to like & getrecommendations! Published in 2022 at "ChemBioChem"
DOI: 10.1002/cbic.202100521
Abstract: Current immunotherapeutics often work by directing components of the immune system to recognize biomarkers on the surface of cancer cells to generate an immune response. However, variable changes in biomarker distribution and expression can result… read more here.
Keywords: cancer cells; activates formyl; peptide receptor; formyl peptide ... See more keywords
Effects of Glucagon‐Like Peptide‐1 Receptor Agonist on Bone Mineral Density and Bone Turnover Markers: A Meta‐Analysis
Sign Up to like & getrecommendations! Published in 2024 at "Diabetes/Metabolism Research and Reviews"
DOI: 10.1002/dmrr.3843
Abstract: Glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) may promote bone formation, but conversely, they could also weaken bones due to the reduction in mechanical load associated with weight loss. However, the clinical effects in humans have not… read more here.
Keywords: meta analysis; like peptide; receptor agonist; peptide receptor ... See more keywords
Comparison of Sodium‐Glucose Cotransporter 2 Inhibitors Versus Glucagon‐Like Peptide‐1 Receptor Agonists and Risks of Osteoarthritis and Arthroplasty in Patients With Type 2 Diabetes Mellitus: A Propensity Score‐Matched Cohorts Retrospective Study
Sign Up to like & getrecommendations! Published in 2025 at "Diabetes/Metabolism Research and Reviews"
DOI: 10.1002/dmrr.70051
Abstract: Sodium‐glucose cotransporter 2 inhibitors (SGLT2is) may have the potential to lower the risk of osteoarthritis through an anti‐inflammatory mechanism. This study compared the risks of new‐onset osteoarthritis and joint replacement surgery between new users of… read more here.
Keywords: cotransporter inhibitors; glucose cotransporter; like peptide; peptide receptor ... See more keywords
Impact of Glucagon‐Like Peptide‐1 Receptor Agonists on the Dementia Incidence in Patients With Type 2 Diabetes Mellitus: A Population‐Based Longitudinal Cohort Study
Sign Up to like & getrecommendations! Published in 2025 at "Diabetes/Metabolism Research and Reviews"
DOI: 10.1002/dmrr.70058
Abstract: Type 2 diabetes mellitus (T2DM) is recognized for increasing the risk of dementia; however, conclusive evidence supporting interventions to mitigate this risk remains elusive. This study endeavours to ascertain whether the glucagon‐like peptide‐1 receptor agonists… read more here.
Keywords: like peptide; diabetes mellitus; type diabetes; receptor agonists ... See more keywords
Pharmacological treatment for patients with obesity and heart failure: Focus on glucagon-like peptide-1 receptor agonists. European Journal of Heart Failure expert consensus document.
Sign Up to like & getrecommendations! Published in 2025 at "European journal of heart failure"
DOI: 10.1002/ejhf.70082
Abstract: There is growing clinical interest in strategies for improving clinical outcomes in patients with heart failure (HF) and obesity. The development of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and of the dual glucose‐dependent insulinotropic polypeptide… read more here.
Keywords: heart; like peptide; peptide receptor; heart failure ... See more keywords